ResearchIn-Press PreviewGastroenterologyImmunology
Open Access |
10.1172/jci.insight.195354
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Chan, J. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Mohsin, A. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Krijgsman, J. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Lindelauf, C. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Mu, Q. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Cavalla, B. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Ji, X. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Streett, S. in: PubMed | Google Scholar
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by
van Unen, V.
in:
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America
4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America
5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America
6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America
Find articles by Davis, M. in: PubMed | Google Scholar
Published June 9, 2026 - More info
Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is marked by chronic intestinal inflammation and dysregulated immunity. Although UC and CD affect different areas of the gastrointestinal tract, both diseases share aberrant CD4+ memory T cell responses, with HLA-DRB1 as a major genetic risk factor. HLA-DRB1 encodes MHC class II molecules that influence the CD4+ T cell receptor (TCR) repertoire, yet how these genotypes shape TCR specificity in IBD remains unclear. Here, we genotyped HLA-DRB1 and profiled 3.13 million TCRb sequences from circulating memory CD4+ T cells in 33 IBD patients (20 UC, 13 CD) and 14 healthy controls. Using the GLIPH2 algorithm, we distilled 468,441 candidates based on CDR3 amino acid motifs into 440 high-confidence TCR specificity groups significantly enriched among individuals sharing HLA-DRB1 alleles. Notably, five specificity groups were IBD-enriched and shared between UC and CD, suggesting common antigen targets in both diseases. We also observed increased frequencies of clonally expanded cytotoxic GZMB+PRF1+ memory CD4+ T cells and KIRs+CD8+ T cells in a subset of risk-allele carriers with IBD. These findings elucidate distinct, HLA-linked TCR specificity groups in IBD and provide mechanistic insights that may advance antigen discovery and personalized medicine.